AEON Biopharma, Inc. (AEON) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $60.59M | +91.1% |
| 2024 | $31.71M | -80.2% |
| 2023 | $159.89M | +11.6% |
| 2022 | $143.24M | +701.2% |
| 2021 | $17.88M | +29905.0% |
| 2020 | $59.6K | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $60.59M | +91.1% |
| 2024 | $31.71M | -80.2% |
| 2023 | $159.89M | +11.6% |
| 2022 | $143.24M | +701.2% |
| 2021 | $17.88M | +29905.0% |
| 2020 | $59.6K | — |